Autopsy report · NCT02807961

Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers

“Transferred study to Antwerp, Belgium”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 10 months before it stopped.
• 42 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Eloxx Pharmaceuticals, Inc.

Sponsor type

Industry

Conditions

Genetic Diseases; Nonsense Mutations

Interventions

ELX-02; Placebo

Participants

42

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.